Table 3.
Antibodies tested | Healthy controls (n = 50) | newly onset IMM (n = 31) | P-value |
---|---|---|---|
CMV-IgM, U/ ml† | 0 (0–0) | 6 (5–11) | 0.000* |
% positive | 0% | 12.90% | 0.020# |
CMV-IgG, U/ ml† | 105 (84–124) | 99 (74–136) | 0.778* |
% positive | 93.90% | 100.00% | 0.279# |
Recent CMV infection | 0% | 16.10% | 0.007# |
% positive |
Levels of CMV-IgM were significantly increased in new-onset IIM patients compared with healthy control groups as was the percentage of CMV-IgM+ and recent CMV infection.
The normal reference of quantitative CMV-IgM, CMV-IgG is 0–22, and 0–14 U/mL, respectively.
Unpaired Mann–Whitney U test.
Fisher's exact test/chi-square test.
The level of CMV-IgM, CMV-IgG median (IQR).